ResearchMoz added Latest Research Report titled ” Alpha Mannosidosis Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2024 ” to it’s Large Report database.
Global Alpha Mannosidosis Market: Overview
With increase in the incidence of alpha mannosidosis worldwide the market for treatment is expected to grow in coming years. Alpha Mannosidosis is a rare inherited condition that leads to problems in organs and tissues of the body. The disease is of three types such as Type I, Type II and Type III. Type I is a mild form, type II is moderate form of disease and most commonly observed, whereas, type III is the severe form of disease. Alpha Mannosidosis affects 1 in every 10, 00,000 people worldwide. Alpha-mannosidosis affects men and women equally across the globe. Bone marrow transplant (BMT) and Enzyme replacement therapy (ERT) are the two treatment options for alpha mannosidosis. Bone marrow transplant (BMT) has been conventionally used universally to treat patients suffering from alpha mannosidosis.
Some of the factors driving this market include market exclusivity of orphan drugs, fee reductions and tax credits, increasing investment in the rare disease treatment etc. However, the factors such as high cost of orphan drugs and lack of awareness are expected to hamper the market demand.
Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=931760
Global Alpha Mannosidosis Market: Segmentation
The alpha mannosidosis market has been segmented based on treatment, indication, end-user and geography. Based on treatment, the market has been segmented into bone marrow transplant (BMT) and enzyme replacement therapy (ERT). Enzyme replacement therapy (ERT) is expected to dominate the market with a considerable share in 2017. With the expected increase in the incidence of alpha mannosidosis the market is expected to grow at a high rate in the next few years. BMT is expected to grow steadily due to the morbidity issues connected with the treatment. In terms of indication, the market has been categorized into type I, type II and type III. The market for type III segment is projected to expand at the maximum rate during the forecast period. Type II accounts for a considerable market share at present. Based on end-user, the market has been segmented into hospitals and specialty clinics. The hospitals segment dominated the market and the trend is likely to continue driven by increasing patient burden due to rise in patient burden.
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html
Table of Content
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Alpha Mannosidosis Market
4. Market Overview
4.1.1. Industry Evolution / Developments
4.2. Market Dynamics
4.3. Alpha Mannosidosis Market Analysis and Forecasts, 2014-2024
4.3.1. Pricing – Actuals and Projections, 2014-2024 (US$ per Unit)
4.4. Porter’s Five Force Analysis
4.5. Market Outlook
5. Alpha Mannosidosis Market Analysis and Forecasts, By Treatment
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Size (US$ Mn) Forecast By Treatment
5.4.1. Bone Marrow Transplant (BMT)
5.4.2. Enzyme Replacement Therapy (ERT)
5.5. Market Attractiveness By Treatment
ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.
Mr. Nachiket Ghumare
90 State Street, Albany NY, United States – 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Follow us on LinkedIn at: http://bit.ly/1TBmnVG
Follow me on Blogger at: http://healthcare-research-report.blogspot.in/